HomeCERO • NASDAQ
add
CERo Therapeutics Holdings Inc
Previous close
$1.41
Day range
$1.37 - $1.47
Year range
$1.33 - $12.38
Market cap
20.17M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 369.34K | -71.31% |
Net income | -282.76K | -7.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -9.45% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 96.87K | -79.64% |
Total assets | 8.56M | -79.79% |
Total liabilities | 22.76M | -57.35% |
Total equity | -14.20M | — |
Shares outstanding | 14.72M | — |
Price to book | -0.62 | — |
Return on assets | -10.84% | — |
Return on capital | 7.38% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -282.76K | -7.65% |
Cash from operations | -186.61K | 49.98% |
Cash from investing | -13.82M | -107.65% |
Cash from financing | -27.68M | 80.04% |
Net change in cash | -41.69M | -200.13% |
Free cash flow | -130.22K | 99.01% |
About
Headquarters
Website
Employees
8